Eradication of H Pylori Infection Reduces Risk for Gastric Cancer
A team of researchers investigated the long-term effects of eliminating H pylori infection in patients at high risk for gastric cancer.
H pylori Infection
H PYLORI INFECTION
Latest Articles
Chronic Bacterial Infections Associated With an Increased Risk for Ischemic Stroke
In this meta-analysis, researchers assessed the relationship between 4 infectious bacteria and the risk for ischemic stroke.
What Are the Extragastric Manifestations of H pylori Infection?
Joseph J. Jennings, MD, and Cynthia L. Sears, MD, describe the systemic effects of H pylori infection and clinical approaches for treating the extragastric complications.
H Pylori Eradication Therapy May Improve Functional Dyspepsia Symptoms
Investigators assessed the efficacy of eradication therapy for the treatment of patients with H pylori-positive functional dyspepsia.
Inverse Relationship Observed Between Alcohol Consumption, H pylori Infection
Investigators assessed the relationship between alcohol consumption and risk for Helicobacter pylori infection.
High Gastrin Levels Caused by Several Factors
Elevated gastrin levels can be a sign of hypergastrinemia or gastrinoma. However, other factors may be the cause. Investigators sought to better understand the difference.
Low Rate of Symptomatic GERD Found After Successful H Pylori Eradication
Investigators assessed clinical predictors and the timing associated with development of symptomatic gastroesophageal reflux disease following H pylori infection eradication.
Trust Your Gut: Diagnosis and Treatment of Keto Rash
Author reviews a case of prurigo pigmentosa in a patient following the ketogenic diet and outlines a strategy to diagnose and treat this condition.
Consecutive Quadruple Therapies for Difficult-to-Treat H pylori Infection
Investigators assessed the safety and efficacy of two 1-week quadruple therapies given consecutively in patients with difficult-to-treat Helicobacter pylori infections.
H pylori Antibiotic Resistance in the US
Investigators analyzed trends in the antibiotic resistance of H pylori within the United States over a 10 year period.
Diagnostic Accuracy of a Simple Endoscopic Program for Patients With Suspected H pylori Infection
Investigators evaluated the diagnostic accuracy of certain mucosal predictors of Helicobacter pylori status and aimed to validate a simple prediction model.
Side Effects of H pylori Eradication Therapies Are Generally Mild, Have Little Effect on Compliance
Investigators assessed the frequency and severity of adverse events associated with H pylori treatments in clinical practice.
Phathom Seeks Approval of Vonoprazan-Based Regimens for H. Pylori Infection
The applications are based on data from the phase 3 PHALCON-HP trial.
Eradication Therapy for H pylori infection Linked to Altered Gut Microbiota, Ghrelin Concentrations
Investigators conducted a study to determine the relationship between gut microbiota and ghrelin concentrations among patients with positive Helicobacter pylori infection vs those with antigen-negative H pylori infection who received eradication therapy.
Resistant Strains of H pylori Across Europe Associated With Historical Antibiotic Use
Investigators assessed the link between antibiotic consumption and resistance and H pylori infections in European countries.
Vonoprazan-Based Triple Therapy: Most Effective Worldwide for H pylori
Researchers performed a network meta-analysis to compare the effectiveness of first-line regimens vs standard triple therapy in the treatment of H pylori infection.
HDDT vs BQT for H pylori Eradication
Researchers compared the efficacy, adverse events, and compliance of HDDT vs BQT as first-line or rescue regimens and investigated factors contributing to H pylori eradication.
H pylori Eradiation Failure More Frequent Among Patients With HIV Coinfections
Researchers aimed to evaluate outcomes of H pylori treatment and identify any risk factors for failure in patients with HIV.
Study Shows Vonoprazan-Based Regimens Noninferior to PPI-Based Triple Therapy
Vonoprazan is an oral small molecule potassium-competitive acid blocker.
Abdominal Pain, Diarrhea in COVID-19 Linked to H pylori Infection
Researchers investigated the effects of H pylori on the clinical presentation and disease course of COVID-19 infections.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in H pylori infection
Loading... 
Loading...